Bupropion
Formulations: - Oral > Solid: 150 mg sustained-release (hydrochloride) Indications: - Nicotine dependence Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Nicotine Replacement Therapy
Vendor: Marketplace supplier
Formulations:
- Local > Topical > Transdermal patch: 5 to 30 mg per 16 hour; 7 to 21 mg per 24 hour
Oral > Solid > lozenge: 2 mg; 4 mg lozenge
Local > Buccal > Oral spray: 1 mg per actuation
Local > Buccal > Chewing gum: 2 mg; 4 mg
Indications:
- Nicotine dependence
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Local > Topical > Transdermal patch: 5 to 30 mg per 16 hour; 7 to 21 mg per 24 hour
Oral > Solid > lozenge: 2 mg; 4 mg lozenge
Local > Buccal > Oral spray: 1 mg per actuation
Local > Buccal > Chewing gum: 2 mg; 4 mg
Indications:
- Nicotine dependence
Source: EML workbook import
Similar Products
Cytisine (Cytisinicline)
Formulations: - Oral > Solid > tablet: 1.5 mg Indications: - Nicotine dependence Source: EML workbook import
MOQ: 1
Kes0.00
Varenicline
Formulations: - Oral > Solid: 0.5 mg; 1 mg Indications: - Nicotine dependence Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.